Senator Dave McCormick, a member of the United States Senate representing Pennsylvania, recently addressed two major issues on his social media account: the threat posed by nitazenes and federal investments in the shipbuilding industry.
On October 30, 2025, Senator McCormick warned about the dangers of nitazenes in a post stating, “Nitazenes could be the next fentanyl—they’re cheap, easy to produce, and up to 40x more lethal. With @POTUS making major strides against fentanyl, traffickers are now turning to nitazenes to kill innocent Americans. That’s why I partnered with my Senate colleagues to introduce https://t.co/LjafASIouH”. In a follow-up tweet posted on the same day, he encouraged readers to learn more: “Read more https://t.co/9lX01KgS7t”.
Later that day, Senator McCormick commented on recent federal investment plans for domestic shipbuilding. He wrote on October 30, 2025: “President Trump is delivering for America’s shipbuilding industry. Out of the $350 billion investment, $150 billion will be directed towards strengthening our shipbuilding here at home— and $5 billion exclusively into the Hanwha @PhillyShipyard to increase its current capacity by https://t.co/rVcakMsTRB”.
Nitazenes are synthetic opioids that have emerged as a significant concern due to their potency and potential lethality. According to experts and public health officials, these substances can be far stronger than fentanyl and are often produced in clandestine laboratories using readily available chemicals. Law enforcement agencies have noted an uptick in nitazene-related incidents as efforts targeting fentanyl disrupt traditional supply chains.
Federal investments in American shipbuilding aim to revitalize critical manufacturing infrastructure and support national security objectives. The allocation of funds toward facilities such as Philly Shipyard reflects broader policy goals focused on job creation and maintaining competitive industrial capabilities within the United States.
